Chiarelli Anna M, Mai Verna, Halapy Erika E, Shumak Rene S, O'Malley Frances P, Klar Neil S
Division of Preventive Oncology, Cancer Care Ontario, Toronto.
Can J Public Health. 2005 Jul-Aug;96(4):259-63. doi: 10.1007/BF03405159.
The effect of severity of screening result on delays to diagnosis has primarily been examined for mammographic abnormalities. This study will examine delays to assessment and diagnosis for women with an abnormal mammogram compared to women with an abnormal clinical breast examination (CBE) or abnormal CBE and mammogram.
Using data routinely collected by Ontario Breast Screening Program (OBSP), 12,675 women aged 50 to 69 with an abnormal screening result between January 1, 2000 and December 31, 2000 were followed prospectively to the completion of their assessment process. Median waiting times from abnormal screen to first assessment procedure and diagnosis were compared by modality of referral and among women with a breast cancer diagnosis by prognostic features.
The median waiting time to first assessment and to diagnosis was significantly longer for women with only a clinical abnormality compared to women with a mammographic abnormality. In addition, women diagnosed with cancers of larger size had longer delays when the abnormality was detected only clinically. However, women referred by both modalities had significantly shorter waiting times to first assessment procedure and to diagnosis of poor prognosis cancers compared to women referred by mammography alone.
Women with an abnormal CBE and mammogram are assessed more promptly and have shorter diagnostic times. However, women with only a CBE abnormality had delays to diagnosis as a result of longer waiting times to first assessment procedure. Integration of the OBSP with assessment centres should improve times to diagnosis irrespective of modality of referral.
筛查结果的严重程度对诊断延迟的影响主要在乳腺钼靶异常方面进行了研究。本研究将对比乳腺钼靶检查异常的女性、临床乳腺检查(CBE)异常的女性以及CBE和乳腺钼靶检查均异常的女性在评估和诊断方面的延迟情况。
利用安大略省乳腺筛查项目(OBSP)常规收集的数据,对2000年1月1日至2000年12月31日期间12675名年龄在50至69岁、筛查结果异常的女性进行前瞻性随访,直至其评估过程结束。根据转诊方式以及乳腺癌诊断女性的预后特征,比较从异常筛查到首次评估程序和诊断的中位等待时间。
与乳腺钼靶异常的女性相比,仅临床检查异常的女性首次评估和诊断的中位等待时间显著更长。此外,当仅通过临床检查发现异常时,被诊断为肿瘤较大的女性延迟时间更长。然而,与仅通过乳腺钼靶转诊的女性相比,两种方式转诊的女性在首次评估程序以及诊断预后不良癌症方面的等待时间显著更短。
CBE和乳腺钼靶检查均异常的女性评估更迅速,诊断时间更短。然而,仅CBE异常的女性由于首次评估程序的等待时间更长而出现诊断延迟。将OBSP与评估中心整合应能缩短诊断时间,而不论转诊方式如何。